Used in cancer research to target ALCAM (CD166), a protein involved in tumor cell adhesion and signaling. This reference antibody supports the development of therapeutic antibodies and diagnostic tools, particularly in solid tumors like colorectal and breast cancer. It enables flow cytometry, immunohistochemistry, and functional assays to study cell-cell interactions and immune responses. Also serves as a benchmark in antibody engineering and bioprocessing for consistency and performance evaluation.